Biometrics 1977, 33: 159–174.CrossRefPubMed 36. Foster C, Evans DG, Eeles R, Eccles D, Ashley S, Brooks L, Davidson R, Mackay J, Morrison PJ, Watson M: Predictive testing for BRCA 1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 2002, 86: 1209–1216.CrossRefPubMed 37. Meiser B, Butow PN, Barratt AL, Schnieden

V, Gattas M, Kirk J, Gaff C, Suthers G, Tucker K, Psychological Impact Collaborative Group: Psychological Impact Collaborative Group. Long-term outcomes of genetic counseling in women at increased risk of developing GM6001 in vitro hereditary breast cancer. Patient Selleckchem Ferrostatin-1 Educ Couns 2001, 44: 215–225.CrossRefPubMed 38. Evans DG, Burnell LD, Hopwood P, Howell A: Perception BAY 11-7082 manufacturer of risk in women with a family history of breast cancer. Br J Cancer 1993, 67: 612–614.PubMed 39. Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS: A systematic review of perceived risk, psychological and behavioural impacts of genetic testing. Genet Med 2008, 10: 19–32.CrossRefPubMed 40. Condello C, Gesuita R, Pensabene M, Spagnoletti I, Capuano I, Baldi C, Carle F, Contegiacomo A: Distress and family functioning in oncogenetic counseling for hereditary and familial breast and/or ovarian cancers. J Genet Couns 2007, 16: 625–634.CrossRefPubMed 41. Lerman C, Trock B, Rimer BK, Jepson

C, Brody D, Boyce A: Psychological side effects of breast cancer screening. Health Psychol 1991, 10: 259–67.CrossRefPubMed Competing interests The authors declare that Sclareol there are no financial or non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) in relation to this manuscript. Authors’ contributions AC main author project of the study and interpretation of the data, CV and BM patient’s data collection, data analysis and interpretation of the data, FMS, FC and AS project of the study and study coordinator.”
“Background Epithelial-mesenchymal transition (EMT) is essential for morphogenesis during embryonic development and is a key event in the tumor invasion and metastatic processes [1]. E-cadherin, a homophilic Ca2+-dependent cell

adhesion molecule located in adherens junctions of epithelia, plays a critical role in the suppression of tumor invasion; its loss of function coincides with increased tumor malignancy [2]. Several EMT-inducing regulators repress E-cadherin transcription via interaction with specific E-boxes of the proximal E-cadherin promoter [3]. Snail-related zinc finger transcription factors are the most prominent ones and we previously examined the relationship between E-cadherin and Snail or Slug expression in ESCC, close relationships were found [4, 5]. Twist, a highly conserved basic helix-loop-helix (bHLH) transcription factor, has been recently identified as a developmental gene with a key role in E-cadherin repression and EMT induction [3].